53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin®) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva®) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer
2006 ◽
Vol 4
(12)
◽
pp. 20
◽
Keyword(s):
Phase Ii
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. TPS8580-TPS8580
◽
Keyword(s):
Keyword(s):